Cargando…

Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma

PURPOSE: Allergen immunotherapy (AIT), when continued for 3 years, is the only disease-modifying treatment for AR and asthma. Adherence is a key to ensure effectiveness, and poor adherence is a contraindication for AIT. The objective of this study was to evaluate real-world adherence to AIT with sub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vogelberg, Christian, Brüggenjürgen, Bernd, Richter, Hartmut, Jutel, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231771/ https://www.ncbi.nlm.nih.gov/pubmed/32494127 http://dx.doi.org/10.2147/PPA.S242957

Ejemplares similares

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study
por: Pfaar, Oliver, et al.
Publicado: (2015)

Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen
por: Ueda, Shoko, et al.
Publicado: (2022)

Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
por: Tsabouri, Sophia, et al.
Publicado: (2017)

Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)

Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines
por: Aboshady, Omar Ali, et al.
Publicado: (2014)

Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
por: Tsabouri, Sophia, et al.
Publicado: (2017)

Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma
por: Wahn, Ulrich, et al.
Publicado: (2018)

Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada
por: Ellis, Anne K., et al.
Publicado: (2021)

Efficiacy of injection specific immunotherapy for grass pollen seasonal allergic rhinitis
por: Wasilewska, Eliza, et al.
Publicado: (2015)

5-grass-pollen SLIT effectiveness in seasonal allergic rhinitis: Impact of sensitization to subtropical grass pollen
por: van Nunen, Sheryl A., et al.
Publicado: (2022)

1,25(OH)(2)VitD3 supplementation enhances suppression of grass pollen-induced allergic asthma by subcutaneous and sublingual immunotherapy in a mouse model
por: Hesse, Laura, et al.
Publicado: (2020)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

Influence of subcutaneous specific immunotherapy on drug costs in children suffering from allergic asthma
por: Reinhold, Thomas, et al.
Publicado: (2013)

Real‐world evidence for the long‐term effect of allergen immunotherapy: Current status on database‐derived European studies
por: Vogelberg, Christian, et al.
Publicado: (2022)

Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment
por: Reinhold, Thomas, et al.
Publicado: (2016)

Update about Oralair® as a treatment for grass pollen allergic rhinitis
por: Klimek, L., et al.
Publicado: (2022)

Sublingual or Subcutaneous immunotherapy for Seasonal Allergic Rhinitis (AR): an indirect analysis of efficacy, safety and cost
por: Dranitsaris, George, et al.
Publicado: (2014)

Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
por: Antolín-Amerigo, Darío, et al.
Publicado: (2017)

Critical appraisal of Timothy grass pollen extract GRAZAX(®) in the management of allergic rhinitis
por: Scaparrotta, Alessandra, et al.
Publicado: (2015)

The Effect of Broccoli Sprout Extract on Seasonal Grass Pollen-Induced Allergic Rhinitis
por: Yusin, Joseph, et al.
Publicado: (2021)

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
por: Malling, H-J, et al.
Publicado: (2009)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
por: Gotoh, Minoru, et al.
Publicado: (2022)

Prevalence of allergic rhinitis and asthma in Poland in relation to pollen counts
por: Lipiec, Agnieszka, et al.
Publicado: (2019)

A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma
por: Murphy, Kevin, et al.
Publicado: (2013)

Effect of sublingual immunotherapy on platelet activity in children with allergic rhinitis()
por: Chen, Yanqiu, et al.
Publicado: (2016)

Nasal microbes in allergic rhinitis children with or without sublingual immunotherapy
por: Shen, Xiao-Fei, et al.
Publicado: (2023)

Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis
por: Zeng, Yinhui, et al.
Publicado: (2023)

Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis
por: Novak, Natalija, et al.
Publicado: (2022)

Urban Tree Canopy and Asthma, Wheeze, Rhinitis, and Allergic Sensitization to Tree Pollen in a New York City Birth Cohort
por: Lovasi, Gina S., et al.
Publicado: (2013)

Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-life
por: Novakova, Silviya Mihaylova, et al.
Publicado: (2017)

PD14 - Non-interventional 2-year study of sublingual immunotherapy in children and adolescents with allergic rhinoconjunctivitis caused by grass pollen
por: Karagiannis, Efstrathios, et al.
Publicado: (2014)

Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study
por: Blome, Christine, et al.
Publicado: (2020)

Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis
por: McDonell, Amanda L., et al.
Publicado: (2015)

Sublingual immunotherapy provides long‐term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real‐world database analysis
por: Zielen, S., et al.
Publicado: (2017)

Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults
por: Ruggeri, Matteo, et al.
Publicado: (2013)

Sensitization to subtropical grass pollens in patients with seasonal allergic rhinitis from Bahia Blanca, Argentina()
por: Ramon, German D., et al.
Publicado: (2019)

5 Posttreatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis
por: Didier, Alain, et al.
Publicado: (2012)

The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children
por: Incorvaia, Cristoforo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8h4ku3sdac6i0ed54d7gthqsdn